Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations
- PMID: 21822207
- PMCID: PMC6368823
- DOI: 10.1038/modpathol.2011.116
Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations
Abstract
The term gray zone lymphoma has been applied to tumors that demonstrate transitional morphologic and immunophenotypic features between classical Hodgkin's lymphoma and diffuse large B-cell lymphoma, especially primary mediastinal large B-cell lymphoma. Histopathological and genetic data are limited for these unusual cases. We analyzed cases of gray zone lymphoma (n=27), mediastinal composite lymphoma (n=3) and mediastinal synchronous/metachronous lymphoma (n=3) by morphology, immunophenotyping and fluorescence in situ hybridization. Mediastinal involvement was assured in 24/33 patients (73%). The patient cohort showed a male predominance (M:F ratio; 20:13) and a median age of 32 years (range, 16-91 years). Patients with mediastinal disease were significantly younger (median age: 29.5 years) than patients presenting without evident mediastinal disease (median age: 55 years). Gains including amplifications in 2p16.1 (REL/BCL11A locus) were observed in 33% of all patients, whereas alterations affecting the JAK2/PDL2 locus in 9p24.1 were present in 55%. Further studies revealed rearrangement of the CIITA locus at 16p13.13 in 8/30 cases (27%) and 7/26 cases (27%) demonstrated gains of 8q24 (MYC). Genetic aberrations involving 2p16.1, 9p24.1 and 8q24 showed a higher incidence in cases with evident mediastinal involvement. However, this was not statistically significant when compared with cases without known mediastinal involvement. Twelve of the 27 cases of gray zone lymphoma were morphologically more reminiscent of classical Hodgkin's lymphoma, whereas the other gray zone lymphomas presented with morphological features more closely resembling large B-cell lymphoma. Both morphological groups of gray zone lymphoma were similarly positive for Cyclin E (75 and 93%) and p63 (50 and 53%, respectively) expression. These findings further support a close relationship between gray zone lymphoma, classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma, and suggest that some cases of gray zone lymphoma without mediastinal disease may share similar genetic alterations.
Conflict of interest statement
Disclosure/conflict of interest
The authors declare no conflict of interest.
Figures




Similar articles
-
Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.Am J Surg Pathol. 2005 Nov;29(11):1411-21. doi: 10.1097/01.pas.0000180856.74572.73. Am J Surg Pathol. 2005. PMID: 16224207
-
Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.Haematologica. 2011 Apr;96(4):558-66. doi: 10.3324/haematol.2010.033167. Haematologica. 2011. PMID: 21454882 Free PMC article.
-
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.Haematologica. 2011 Feb;96(2):262-8. doi: 10.3324/haematol.2010.030809. Epub 2010 Oct 22. Haematologica. 2011. PMID: 20971819 Free PMC article.
-
[Lymph node pathology - an update].Pathologe. 2013 Feb;34(1):34-44. doi: 10.1007/s00292-012-1706-5. Pathologe. 2013. PMID: 23319007 Review. German.
-
Primary mediastinal (thymic) large B-cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma.Arch Pathol Lab Med. 2011 Mar;135(3):394-8. doi: 10.5858/2009-0463-RSR.1. Arch Pathol Lab Med. 2011. PMID: 21366467 Review.
Cited by
-
Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.Clin Cancer Res. 2014 May 15;20(10):2674-83. doi: 10.1158/1078-0432.CCR-13-3007. Epub 2014 Mar 7. Clin Cancer Res. 2014. PMID: 24610827 Free PMC article.
-
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.Med Mol Morphol. 2013 Sep;46(3):172-6. doi: 10.1007/s00795-013-0038-8. Epub 2013 Mar 20. Med Mol Morphol. 2013. PMID: 23512149
-
Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report.Front Oncol. 2024 Jan 19;13:1254256. doi: 10.3389/fonc.2023.1254256. eCollection 2023. Front Oncol. 2024. PMID: 38313213 Free PMC article.
-
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.Diagn Pathol. 2019 Dec 12;14(1):133. doi: 10.1186/s13000-019-0918-x. Diagn Pathol. 2019. PMID: 31831043 Free PMC article.
-
Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.Diagnostics (Basel). 2022 Jun 20;12(6):1507. doi: 10.3390/diagnostics12061507. Diagnostics (Basel). 2022. PMID: 35741318 Free PMC article. Review.
References
-
- Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol 1986;10: 176–191. - PubMed
-
- Gonzalez CL, Medeiros LJ, Jaffe ES. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin’s disease and B-cell non-Hodgkin’s lymphoma. Am J Clin Pathol 1991;96:81–89. - PubMed
-
- Zarate-Osorno A, Medeiros LJ, Longo DL, et al. Non-Hodgkin’s lymphomas arising in patients successfully treated for Hodgkin’s disease. A clinical, histologic, and immunophenotypic study of 14 cases. Am J Surg Pathol 1992;16:885–895. - PubMed
-
- Zarate-Osorno A, Medeiros LJ, Kingma DW, et al. Hodgkin’s disease following non-Hodgkin’s lymphoma. A clinicopathologic and immunophenotypic study of nine cases. Am J Surg Pathol 1993;17:123–132. - PubMed
-
- Garcia JF, Mollejo M, Fraga M, et al. Large B-cell lymphoma with Hodgkin’s features. Histopathology 2005;47:101–110. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous